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Abstract
The musical practice is an extremely complex activity that involves a series 
of cognitive abilities and functions, among them are hearing, memory, motor 
coordination, attention, affection, mathematical calculation, and the association 
of all of these concomitantly, including situations of public exposure. Because of 
this, musical performance is particularly susceptive to anxiety symptoms. Musical 
performance anxiety (MPA) is defined as an experience of persistent and distress-
ing apprehension and/or real prejudice of the performance abilities in a public 
context in an unjustifiable degree given the individual musical aptitude and prepa-
ration level. It prevails more commonly on the female gender in a 3:1 proportion and 
affects about 20% of the professional musicians. In the present chapter, its main 
etiologies and psychic mechanisms, evaluation instruments, as well as the current 
therapeutic strategies available will be presented.
Keywords: performance anxiety, musical performance anxiety, musicians, perceived 
causes, psychological intervention, drug therapies, optimal performance
1. Introduction
The musical practice is an extremely complex activity that involves a series of 
cognitive abilities and functions, among them are hearing, memory, motor coordi-
nation, attention, affection, mathematical calculation, and the association of all of 
these concomitantly, including situations of public exposure [1]. Because of this, 
musical performance is particularly susceptive to anxiety symptoms.
Anxiety in itself is, up to a certain point, something favorable to the perfor-
mance [2], since it helps the performer to perceive what favors him and disregard 
what could hinder his performance. After a certain point, anxiety starts to influence 
negatively the musical performance efficiency, according to the Yerkes-Dodson 
curve.
Musical performance anxiety (MPA) is a term that encompasses many dimen-
sions and started being described in 1990. It is the experience of a persistent and 
distressing apprehension and/or real prejudice of the performance abilities in a 
public context in an unjustifiable degree given the individual musical aptitude and 
preparation level [3].
In the musical environment, MPA has been called as “stage fright” although 
MPA encompasses something much bigger than that [4]. The reason is that MPA has 
three axes that complement each other in terms of subjective manifestations of this 
picture.
Anxiety Disorders
2
Performance anxiety affects equally music professional and students. There is 
a prevalence of around 18% [5]. The main reported symptoms are concentration 
decrease, tachycardia, tremor, sweating, and xerostomia, which are severe enough 
to negatively impact on the performance level [5, 6].
In the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, or 
DSM-5, social anxiety disorder (SAD) is highlighted, in which the subject feels fear 
or anxiety in social interaction situations when he worries about the possibility of 
coming to be evaluated by the public [4].
In the present chapter, general aspects of MPA, its possible etiologies, its occur-
rence in the diverse age groups, the instruments of evaluation, and, at last, the 
therapeutic approaches will be approached.
2. MPA pathogenesis, susceptibility, and vulnerability
MPA is a complex phenomenon caused by the interaction of many factors, 
including genetics, environmental stimuli and individual experience, emotions, 
cognitions, and personal behavior.
Factors like age, gender, the kind of musical instrument, musical background, 
musical perception, perfectionism, and emotions compose the group of personal 
variables that can interfere more or less on the MPA levels [4, 7].
Although MPA can begin in childhood, the literary data are conflicting. While 
some studies suggest that in this age group there are no significant differences between 
the genders [8], others point out that there are significant differences in many 
parameters (physiological, cognitive, behavioral, and subjective perception) [9]. For 
example, the girls tend to show an anticipatory anxiety and also during the perfor-
mance, while the boys only show anxiety during the performance. This profile seems 
to present itself gradually even more unfavorable to the female gender as age advances 
[10]. These data indicate that women are significantly less confident and more anxious 
and show less self-efficacy (attitude) in contexts such as jazz improvising learning. 
In women over 45 years old, the MPA prevalence is even bigger and can achieve up to 
60% depending on the context [11]. However, there is a great relation between MPA 
and age increase among susceptible individuals, independently of the gender.
The way in which each individual processes his beliefs about the performance 
situation and how he perceives the way his somatic anxiety reactions affect his 
performance. This behavior is related to perfectionism. Perfectionism, a  personality 
valence, is a complex and multidimensional construction that goes beyond the 
simple search for perfection. It concerns the fight for unreal self-imposed patterns, 
a fixed mentality, high levels of self-criticism, or expectation of high patterns of 
performance by a third party. This distorted expectation about one’s own perfor-
mance ends up influencing negatively self-confidence, and this, ultimately, can 
sabotage the performance quality.
Figure 1. 
The Yerkes-Dodson curve.
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Another important aspect that has been studied is the public impact over the 
performer [6]. In situations where the musicians are being judged in some kind of 
competition or selection, there is a significantly bigger incidence of symptoms such 
as tachycardia and anxiety observed compared to situations that do not involve 
judgment.
The three causes of MPA most commonly cited by musicians are pressure from 
self, excessive arousal, and inadequate preparation for performance [12]. Beyond 
personal impressions there seems to be a combination between genetic vulnerability 
and the learning environment [4, 7]. This learning environment is the result that 
builds a psychic pattern confrontation of the performance situations. This building 
is the sum of the situations that involve familiar experiences with teachers, col-
leagues, tests, and performances.
The Barlow model seems to be the most consecrated among the MPA scholars. It 
consists of an integrated group of three vulnerabilities: biological (genetics, endo-
crine, etc.) and psychological, that is, referring to the subject psychic formation and 
more specific psychological issues in which the environmental stimuli are processed 
according to the patterns learned by the individual [5, 13–15].
The psychological vulnerabilities are structured by elements like affection, 
cognition and its processing, attention, and personality traits [13, 15]. All these 
elements are processed together. For example, when attention is deviated from the 
performance priority objects, it can sabotage its own efficiency. The hyper-focus in 
a determined aspect of the performance can, equally, cause the performer to lose a 
systemic view of what is being presented.
The previous musical experiences and other experiences related to anxiety 
involved in personal and professional histories are also important in the MPA 
genesis [4].
Therefore, the most vulnerable profile to MPA can be identified. The subject that 
feels anxious only in the presence of the public and in front of them has unrealistic 
beliefs about his own potential is the most specific profile. This characteristic 
was also described in the DSM-5 new edition which “seems to represent a distinct 
subgroup of social anxiety disorder in etiology terms, initial age, physiological 
response, and treatment [16].
3. MPA in children and adolescents
Since the first childhood (up to 7 years old), MPA is rarely manifested, differ-
ently from adults/elderly ones [17]. On the contrary, children tend to show others 
their “feats” in a pleasurable way. The question is that this same subject, some years 
later, starts to develop a behavior opposite to this, avoiding to a maximum his own 
exposure to whoever it is.
The main factors that lead to this change in attitude are the innate temper, the 
trace of anxiety, the broadening of the integrated capacity of cognition, the auto-
reflexive function, and the accumulation of the anxiogenic interpersonal experi-
ences. The conjunction of these factors contributes for the formation of beliefs and 
emotions during performance in the adolescence [18].
The emotions that emerge in moments that precede the performance are positive 
as well as negatives. This occurrence of joint affections in general is uncomfort-
able. Therefore there is the need to work on recognizing this emotion/affection so 
that afterwards, there is a control of this situation. However, the reception given 
by the parents, teachers, and more experienced colleagues is fundamental for a 
better processing of these beliefs on behalf of the younger musicians, especially 
preadolescents.
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It was observed that the students who started the musical practice after 7 years 
of age showed higher anxiety scores when compared to those who started at the 
age of 7 or less [19]. This has direct implications in the preventive strategies against 
MPA among children and adolescents. These strategies should privilege the recre-
ation and in every opportunity minimize the negative aspects of the performance; 
in other words, the occurrence of some mistakes in the face of countless right ones 
does not matter.
4. MPA evaluation instruments
Currently, about 20 instruments validated in the English language1 to evaluate 
MPA are available [3]. The majority of these scales is generic, that is, they are not 
specific for an instrument, although some are. There is the Piano Performance 
Anxiety Scale and the Stage Fright Rating Scale (specific for string musicians). 
Many of them are adaptations of the already existing scales for anxiety evaluation. 
These scales are aimed at the musicians’ adult population. The K-MPAI and per-
fAIM scales will be highlighted as follows.
The K-MPAI is the MPA evaluation instrument that has more validations for 
other idioms in the world [20]. Its original version had 26 items, and the most recent 
one, published in 2009, has 40 items. The Appel’s Personal Report of Confidence as a 
Performer (PRCP) and the Performance Anxiety Inventory (PAI) structured them-
selves having as their referential the three components of the Barlow Theory [3]; in 
other words, such scales encompass physiologic, cognitive, and behavioral aspects. 
In K-MPAI the people interviewed use a Likert-type scale of 7 points to answer each 
question, where zero represents no observed anxiety symptom and 6 represents 
extremely high levels of anxiety. Therefore, the score can vary from zero (Ø) to 240 
points. A search to find a cutoff point has been made; however, the cut-off point 
concerning each test criteria vary, suggesting that the K-MPAI cutoff point depends 
on the clinical interest of each patient [20].
Another validated scale in 2011 was the PerfAIM [21]. The PerfAIM comprise 58 
declarations divided into 34 items and 24 subitems. The possible scores vary from 
58 to 290. Due to the normal standard distribution, the scale author suggested that 
the scores between 100 and 205 corresponded to the MPA normality band under 
stressful situations, whereas values above these are associated to extreme cases 
which would demand more attention. Besides, this reference interval can help to 
establish a level of comparison among the subjects, independently of the sample.
The K-MPAI-A is the correlative to K-MPAI for adolescents from 12 to 19 years 
old [8]. Despite being an instrument aimed at young ones in this age group, it was 
applied in other studies including 7-year-old children. Such as the version for the 
adult population, its structure also encompasses the physical, behavioral, and cog-
nitive aspects; however, there are only 15 questions. The fulfilling scheme follows 
the K-MPAI for adults, so it is also the Likert type.
The main contribution of these scales is the assistance of the subjects and, 
together with other approach strategies, the structure of a continuous segmented 
project and, if necessary, subject treatment.
5. MPA management, treatments, and approach strategies
The MPA involves, in general, combined strategies. These strategies can be 
divided in therapies, medicinal intervention, and other approaches. The first 
1 Some of them are validated in more than 20 languages.
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published studies that investigated the MPA non-pharmacological treatments are 
dated from the beginning of the 1980s, while the pharmacological studies started in 
the late 1960s decade [14].
5.1 Therapies
Among the therapeutic interventions, the main strategies pointed out in the lit-
erature are behavioral therapy, cognitive therapy, cognitive-behavioral therapy [14, 
22–25], hypnosis [24–26], and, more recently, the Acceptance and Commitment 
Therapy (ACT) [27].
The cognitive and behavioral therapies have as their main objective to approach 
emotions and dysfunctional behaviors. The interest is in accessing thought pat-
terns that form themselves and become more and more disabling if not treated. 
Therefore, these therapies aim at a change of faulty thought styles and their conse-
quent inadequate behaviors [25].
The desensitizing process present in the cognitive-behavioral therapy allows, 
through guided images, the scene that generates anxiety to be gradually trans-
formed in something more adaptive that does not involve anxiety. The reason is that 
learned answers can be substituted by more adaptive behaviors [25].
Hypnosis or hypnotherapy consists in inducing the patient to a state of sleepi-
ness, easing the access to issues that involve the problems of nonadaptive behavior 
or dysfunctional thoughts. This access would allow an awareness to begin a change 
process in the way the subject deals with situations that generate MPA [25].
The Acceptance and Commitment Therapy is one of the most recent therapies 
of the third wave in which the dialectical behavioral therapy, the metacognitive 
therapy, and the depression therapy based on mindfulness are also part of it [27]. 
The focus of this therapy is the promotion of full attention and someone’s emotional 
suffering acceptance instead of the symptom domain or control as in the conven-
tional cognitive behavioral therapies.
5.2 Strategies and complementary therapies
Besides the classic therapies, there are MPA complementary control strategies. 
Among them expressive arts therapy (in which one is exposed to virtual reality 
[images] and music therapy), yoga, meditation, the Alexander technique, biofeed-
back, neurofeedback, and transcranial stimulation [23, 25] can be mentioned.
Image-guided therapy consists of employing internal images of the subjects to 
reveal and access internal conflicts that possibly relate themselves to the MPA gen-
esis. This method is used frequently in sports performance [25, 28]. For this kind of 
strategy, the results show MPA level reduction, discomfort improvement, increase 
of self-confidence, and decrease of heart rate [23].
Music therapy, in turn, promotes a better musical and musicality perception and 
decreases the stress like distractibility [25].
There are few studies about the yoga impact on MPA [23]. In the few available 
studies, improvements of the MPA indicators, including humor, sleep and osteoar-
ticular disturbances, and stress, were observed.
There are still no evidences that meditation alone can, in some unquestionable 
way, contribute to decrease the MPA indicators [23]. The few available studies only 
raise questions that speculate that meditation can be related to an improvement in 
some parameters such as heart rate.
The Alexander technique consists of closely observing the individual’s attitude 
and, in the musical practice sphere, trying to check the more accurate possible 
causes of tension in the performer’s body. Therefore, this technique can relieve 
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muscle tensions and contribute to decrease the factors that impact, directly or 
indirectly, the MPA levels [29].
Biofeedback has been used for about 70 years in the experimental psychology 
and neurology fields [30]. It is a technique to accurately measure some organic data 
such as brain waves, heart rate, respiratory rate, muscle activity, and skin tempera-
ture. The main objective of this technique is to provide learning of the self-control 
of these functions. Thus, biofeedback can be part of a strategy to treat anxiety since 
it contributes to control part of the symptoms which are part of MPA. It is usually 
associated with other strategies [30, 31].
Neurofeedback is a kind of biofeedback that teaches individuals the self-control 
of brain functions, measuring the brain waves and providing a feedback signal. 
Neurofeedback usually does not provide an audio and/or video feedback. Positive or 
negative feedback is produced for desired goals or undesirable brain activities, respec-
tively [32]. There are seven kinds of feedback, two of which are indicated for anxiety 
treatment, which makes this technique potentially suitable for treating MPA. The 
more frequent neurofeedback used is the frequency/power neurofeedback. It is used 
to alter the amplitude or velocity of specific brain waves in specific brain areas to treat 
TDAH, anxiety, and insomnia. This technique usually includes the use of two to four 
surface electrodes, sometimes called neurofeedback. There is a second modality called 
low energy neurofeedback system (LENS) which provides weak electromagnetic sig-
nal to alter brain waves on the patient while he is motionless and with his eyes closed. 
This kind of feedback has been used to treat traumatic brain injuries, TDAH, insom-
nia, fibromyalgia, restless legs syndrome, anxiety, depression, and irritability [33].
About 25% of the cases that involve anxiety are not responsive to conventional 
therapies and the psychopharmacological resources. The transcranial magnetic 
stimulation (TMS) is a noninvasive method created in 1985 [34]. TMS is based on 
the Faraday Law—electromagnetic induction—through which the electric activity 
of the brain tissue can be influenced by the magnetic field, therefore inducing an 
electrical current that depolarizes the neurons. In this context, TMS in its repetitive 
form, that is, rTMS, can modulate the cortical excitability besides the stimulation 
period in itself, originating its potential application as a clinical treatment for a 
variety of neurological and psychiatric disturbances, like the anxiety one [34, 35].
Other two noninvasive strategies of low cost are the physical activity and induc-
tion of the flow state. The regular physical activity, especially the aerobics modal-
ity, provides a decrease in anxiety levels [36, 37]. The literature data are robust in 
demonstrating the beneficial effect of the physical activity on anxiety scenarios. 
There are data which demonstrate that this evidence also applies to MPA [36].
On the other hand, the “flow state” is a state of awareness of the hyper-focus in 
which irrelevant details and intrusive thoughts about the performance are elimi-
nated, resulting in the subject being fuller in the final activity which is the musical 
performance. In this context it would be a complete absorption in a determined task 
with enhanced performance skills [15, 26]. There seems to be an inverse relation 
between the flow sate and MPA [38]. From this relation a facilitator model was 
built for the flow state based on three factors: subject preparation, qualification of 
the teachers to deal with this focus, and the building of the flow experience [15]. 
These three axes are linked among themselves and necessarily need to access some 
valences such as learning/preparation that involves well-being, creativity, motiva-
tion, and musical skill mobilization [15, 26, 38].
5.3 Pharmacotherapy
MPA is limited to a determined situation that usually occurs on stage. Therefore, 
to do a medicament intervention, one must consider the need of using psychotropic 
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or not. This will depend on, to a large extent, the frequency the subject is exposed to 
this situation and, certainly, its intensity.
Another important aspect is that the isolated use of drugs does not contribute 
for a change in the performer’s attitude towards MPA. In this regard, the combined 
treatments involving countless psychotherapy alternatives and complementary 
therapies are highly recommended [25].
In the musical environment, the two most used drug types for the acute MPA 
treatment are the beta-blockers, mainly represented by the propranolol and 
benzodiazepines (BDZ) which have as their principal representatives alprazolam, 
diazepam, and bromazepam.
The use of BDZ is controversial. If, on the one hand, it has a relatively fast and 
well-tolerated beginning action, on the other hand, its long-term use can cause a 
dependency syndrome, becoming tolerant to the doses, which tends to cause an 
abusive and uncontrolled use [39]. Besides, the fact that they can cause sleepiness 
can compromise, in an import way, the musical performance. Therefore, the use of 
this drug must be very careful so that one uses the minimum possible.
In the cases where there is a prolonged and inadvertent use of these anxiolytic 
classes, employing combined strategies as a gradual discontinuation of the drug, 
followed by psychotherapeutic accompaniment and regular orientations about the 
collateral effects and commitment of the cognitive functions, is recommended.
The BDZ are usually prescribed in association with antidepressive drugs (these 
will be approached further on). The best answer taxes are around the sixth week of 
use [40]. The average daily doses found in the literature are, respectively, clonaz-
epam 2.4 mg/day, bromazepam 21 mg/day, and alprazolam 4.2 mg/day.
The beta-blockers are very efficient in the containment of somatic symptoms, 
mainly the tremors and muscle tension; however, they do not have any action on the 
cognitive and behavioral symptoms [41].
Considering the most severe cases, there is always the possibility of comorbidity 
with other anxiety situations. This issue will be approached in the next topic.
The majority of the literary review studies about the strategies to handle MPA 
do not include psychotropic use [23]. However, basing on the recommendation that 
combined strategies are more efficient and considering that in the most severe cases 
the use of drugs will be necessary, one can, for example, adopt protocols to treat a 
social phobia [42] which, besides being a disorder of the common anxiety, is a situa-
tion that has the closest conceptual relations to MPA.
The psychotropic of the first-line choice are the selective serotonin reuptake 
inhibitors and dual serotonin-norepinephrine reuptake inhibitors (SNRIs) due to 
their efficacy and tolerability profile. The nonselective monoamine oxidase inhibi-
tor, phenelzine, can be stronger than these two drug classes, but, due to its potential 
to interact with food and drugs, its use should be restricted to patients that do 
not respond to selective serotonin reuptake inhibitors or serotonin-noradrenaline 
reuptake inhibitors [40].
The initial alternatives include duloxetine, buspirone, hydroxyzine, pregabalin, 
or bupropion, in this order. If the response is unsatisfactory, the second recommen-
dation is to try a different SSRI. If the answer to the second SSRI is unsatisfactory, 
the recommendation is to try a serotonin-norepinephrine reuptake inhibitor [43]. 
Other alternatives for SSRIs and SNRIs for patients resistant or intolerant to the 
treatment include tricyclic antidepressants, second generation of antipsychotics, 
and valproic acid.
There is less information available about the ideal treatment duration, although 
it has been observed that individuals who abandoned the treatment with less 
than 12–20 weeks have shown more relapses compared to the ones who continued 
making regular use of the medication [40–44]. The existing data suggest that it is 
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reasonable to keep the treatment for at least 3 to 6 months after the situation has 
been stabilized, and this period can be even longer depending on the severity and 
individual characteristics of each subject [44].
In this context, other classes of drugs could be employed; however, there are no 
systematic reviews whose focus is the social phobia treatment. Nevertheless, the 
treatment protocols of other anxiety situations, such as generalized anxiety, can 
be considered. In this regard the following classes can be cited: (1) anticonvulsant 
drugs such as pregabalin for at least 24 weeks and (2) atypical antipsychotic of con-
trolled release such as quetiapine, which reduce the chance of an anxiety upsurge 
[42]. Pregabalin, alternatively, can be employed in monotherapy in daily doses 
between 450 and 600 mg and is recommended as a first-choice agent for the social 
anxiety disorder [45]. Its beginning action is on the first week, and, in general, it 
shows less collateral effects than the BDZs.
Other still very recent pharmacotherapies can be cited as the use of botulinum 
toxin (BT) and cannabidiol. Recent studies indicate that the botulinum toxin 
injection on the glabella reduces the amygdala response with antidepressive effects 
[46]. If the BT effect in humor is, in part, due to the decrease in negative emotions 
in general, it is reasonable to suppose that other psychiatric disorders, such as social 
anxiety disorder, where negative emotions are highlighted, can respond to the BT 
glabellar injection.
Regarding cannabidiol, there is a growing evidence of studies in humans and 
animals that indicate this compound, the principal non-psychotomimetic phyto-
cannabinoids present in Cannabis sativa, as an option to alleviate the anxiety in 
paradigms assessing fear. More recently, the effects of cannabidiol on learned fear 
have been investigated in clinical studies with relevance for clinical application in 
phobias [47]. In such studies the evidence shows that cannabidiol can be a useful 
option to treat social anxiety [48].
More recently the anxiolytic effect of melatonin was shown [49]. Melatonin is 
a hormone secreted by the pineal gland during the night. The melatonin receptors 
(MT2) seem to relate with mechanisms of decrease in anxiety levels. Besides, there 
is evidence that melatonin can stimulate the dopaminergic synthesis in the hippo-
campus, which contributes to suppress the induced stress behavior [50].
5.4 MPA prevention
Preventing MPA means to employ strategies in which the most vulnerable sub-
jects can have access to a context in more favorable environments. Such strategies 
can be applied to the beginners as well as the professionals.
The learning/preparation process should involve well-being, creativity, motiva-
tion, and musical ability mobilization [15, 26, 38]. It is necessary to simulate the 
negative scenarios so that such situations can be trained in an imaginary way as well 
as a real one.
The exposition situation cannot be something new or unexpected for the 
performer. The oriented and repeated experience in stage situations allows the 
performer to become familiar with potentially anxiogenic stimuli. As these stimuli 
are faced without prejudice for the subject integrity, new situations must be 
created in order to develop handling and competence abilities to deal with them. 
This process needs to be regular and with a weekly frequency so that the situations 
can be assimilated and issues, such as attitude and creativity, can become part of 
a defense arsenal for each individual facing anxiogenic “scenes.” There are many 
music graduation courses that structure activities of this nature, called perfor-
mance workshop.
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From the pharmacological strategies’ point of view, it is important to detect the 
procedure as early as possible in the most severe cases, which have indication to use 
psycho-medicines.
5.5 MPA monitoring strategies
The early MPA detection is fundamental for a program of strategies for the 
subject’s monitoring. The differentiated attention towards these individuals must 
include monitoring with screening tests, individual care, and the structuring of an 
activity plan that includes the gradual practice of public exposure.
The forming of vulnerable individual groups contributes for each one of them 
to perceive that their distresses are not exclusive or a rarity. The group can act as a 
facilitator of an encouraging experience.
The pedagogical, therapeutic, and medical dimensions must be shared. Each 
context requires that other dimension be known, even for creating a sharing envi-
ronment where each one of the knowledge can intervene in determined situations. 
Thus, the pedagogical dimension needs to be in agreement with the therapeutic 
strategies, and the medical interventions need to know the context of the musical 
performance, the specificities and discomfort of each musician, as well as their 
routines and technical requirements [51].
6. Comorbidities
There are not many studies about comorbidities in MPA. The literature results 
indicate that the specific phobia, generalized anxiety disorder, panic disorder with/
without agoraphobia, and major depression disorder (but not dysthymia) are the 
common comorbidities [3, 52].
Furthermore, one third of the subjects that show severe MPA also show a 
 generalized anxiety disorder. There are studies that point to a prevalence of a 19 
and 20% comorbidity of social phobia and depression, respectively [53]. This social 
phobia prevalence among musicians is about 10 times more prevalent than the 
general population.
On the other hand, more recent studies indicate that the generalized anxiety 
disorder is the strongest MPA predictor among all major DSM-5 anxiety types [54].
There is a model that proposes three MPA subtypes: MPA1, which is a variety 
restricted to the focus on the performance itself; MPA2, which establishes connec-
tions between (and with) social anxiety/social anxiety disorder; and MPA3 which 
establishes close relations with other nosologies in the anxiety spectrum such as 
panic disorder with or without depression [3, 55]. These relations configure a poten-
tial MPA worsening as other disorders manifest themselves, in a way that MPA will 
not necessarily convert itself in another anxiety disorder or establish a comorbidity 
but there is this potential.
7. Conclusion
These data indicate that MPA is complex and multifactorial. Probably the first 
symptoms are of an early start. Consequently, there is the importance of spread-
ing the information about MPA, especially in the family level and the school/
academic environment, contexts where the future professional musicians are 
formed.
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Preventively, in the family environment as well as in the schools, one must build 
relationships that privilege the well-being, motivation, and reception of psychic 
distresses.
MPA has a worrying prevalence of about 20% among the professional musi-
cians. This number can mean some million subjects! The preventive strategies, 
the qualitative and quantitative evaluation, and the management of the already 
installed situations are of upmost importance.
Currently there are countless strategies to approach MPA. They go from the tra-
ditional psychotherapy strategies (cognitive, behavioral, and cognitive-behavioral 
therapies) to the pharmacological resources. New approaches signal a new outlook 
in this area with the therapeutic use of cannabidiol, melatonin, botulinum toxin, 
neurofeedback, and transcranial stimulation.
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